Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.04M Buy
128,327
+181
+0.1% +$2.81K 0.01% 587
2026
Q1
$1.73M Buy
128,146
+28,316
+28% +$396K 0.01% 602
2025
Q4
$1.24M Buy
99,830
+8,519
+9% +$91.9K 0.01% 631
2025
Q3
$904K Sell
91,311
-37,683
-29% -$367K 0.01% 738
2025
Q2
$1.15M Sell
128,994
-59,133
-31% -$500K 0.01% 661
2025
Q1
$1.64M Buy
188,127
+5,035
+3% +$52.9K 0.02% 562
2024
Q4
$2.28M Buy
183,092
+20,878
+13% +$257K 0.02% 493
2024
Q3
$1.88M Buy
162,214
+3,545
+2% +$40.9K 0.02% 532
2024
Q2
$1.69M Sell
158,669
-3,067
-2% -$33.9K 0.02% 537
2024
Q1
$1.93M Buy
161,736
+8,336
+5% +$100K 0.02% 528
2023
Q4
$1.66M Sell
153,400
-12,018
-7% -$115K 0.02% 520
2023
Q3
$1.63M Buy
165,418
+886
+0.5% +$9.23K 0.02% 512
2023
Q2
$1.64M Buy
164,532
+1,099
+0.7% +$10.5K 0.02% 509
2023
Q1
$1.57M Buy
163,433
+7,026
+4% +$77.9K 0.02% 519
2022
Q4
$1.74M Buy
156,407
+22,762
+17% +$238K 0.03% 477
2022
Q3
$1.14M Buy
133,645
+21,973
+20% +$216K 0.02% 534
2022
Q2
$1.17M Buy
111,672
+33,434
+43% +$367K 0.02% 527
2022
Q1
$851K Buy
78,238
+1,885
+2% +$24.8K 0.01% 657
2021
Q4
$1.03M Buy
76,353
+14,236
+23% +$190K 0.02% 591
2021
Q3
$842K Sell
62,117
-5,526
-8% -$78.4K 0.02% 637
2021
Q2
$967K Buy
67,643
+15,533
+30% +$225K 0.02% 612
2021
Q1
$728K Sell
52,110
-1,415
-3% -$23.1K 0.02% 613
2020
Q4
$1M Buy
53,525
+32,221
+151% +$526K 0.02% 464
2020
Q3
$316K Buy
21,304
+463
+2% +$7.39K 0.01% 840
2020
Q2
$335K Buy
+20,841
New +$338K 0.01% 788

Other funds holding VTRS

Xponance's VTRS Position: Q2 2026 in Review

Xponance increased its Viatris (VTRS) stake by 0.14% in Q2 2026, buying an estimated $2.81K and bringing the position to 128,327 shares worth $2.04M. The position accounts for 0.01% of the portfolio, ranked #587.

Xponance first reported a position in VTRS in Q2 2020 and has held it in 25 quarters since. The position peaked at $2.28M in Q4 2024. 1,026 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Xponance held 128,327 shares of Viatris worth $2.04M as of Q2 2026.
  • Xponance bought 181 Viatris shares in Q2 2026, an estimated $2.81K.
  • Viatris made up 0.01% of Xponance's portfolio in Q2 2026, its #587 holding.
  • Xponance first reported a position in Viatris in Q2 2020 and has held it in 25 quarters since.
  • Xponance's Viatris position peaked at $2.28M in Q4 2024.
  • 1,026 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.